SAAS moves

International hotel chain taps Houston staffing startup to get teams back to work

Choice Hotels has a new partner in Houston-based WizeHire. Photo courtesy of Choice Hotels

A Houston startup has struck a deal with a major new client focused on getting employees back to work at its 6,000 locations worldwide.

Maryland-based international hotelier Choice Hotels International Inc. selected Houston-based WizeHire into its Qualified Vendor program as its only current recruiting solution for the thousands of franchised locations under the Choice Hotels umbrella. WizeHire provides its clients tech-enabled, customized hiring solutions and has a suite of software available for users to utilize.

"We're so excited to support Choice's independently-owned hotels with the most personal and complex part of their businesses—hiring great talent," says Sid Upadhyay, WizeHire's co-founder and CEO, in a press release.

According to data from the U.S. Bureau of Labor Statistics, the hospitality industry saw an unemployment rate of 13.5 percent. With travel expected to increase this year, Choice Hotels is looking to provide its franchisees opportunities to efficiently rehire.

"As a long-time Choice Hotels owner and WizeHire customer, I'm thrilled for what this partnership means for growing my business," says Tushar Patel, owner of Quality Inn & Suites Round Rock - Austin North, in the release.

Hospitality represents one of the six industry verticals WizeHire has listed on its website, and the startup provides "job templates created with industry experts, built-in pre-screening tools specifically for hospitality jobs and benchmarks that help identify the soft skills needed for numerous hotel roles," according to the release.

Choice Hotels nationwide will have access to these resources effective immediately, per the release.

"At a time when there is so much uncertainty for many individuals and employers in the hospitality industry, WizeHire has the opportunity to meet hiring needs at this critical moment," says Justin Nimergood, head of franchise sales for WizeHire. "I'm thrilled to be leading that charge."

After a tumultuous year in which hiring across industries essentially came to a halt, WizeHire is seeing immense business growth as companies plan to rehire, says Upadhyay in a recent interview with InnovationMap. The company recently raised a $7.5 million series A round to gear up for this growth.

With all the uncertainty last, Upadhyay says he and his team instead focused on providing resources, such as PPP loan guidance, for small businesses — something the company is focused on continuing.

"We're really going beyond just the hire," Upadhyay says in a recent episode of the Houston Innovators Podcast. "We're getting to this role where we're going to help you grow your business."

Listen to Upadhyay on the Houston Innovators Podcast:

Trending News

Building Houston

 
 

Dr. Peter Hotez and Dr. Maria Elena Bottazzi have been recognized by Fast Company for their leadership in developing low-cost COVID vaccine. Photo courtesy of Texas Children's

This week, Fast Company announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made the cut.

Dr. Peter Hotez and his fellow dean of the National School of Tropical Medicine at Baylor College of Medicine, Dr. Maria Elena Bottazzi, were named among the list for “open sourcing a COVID-19 Vaccine for the rest of the world.” The list, which recognizes individuals making a cultural impact via bold achievements in their field, is made up of influential leaders in business.

Hotez and Bottazzi are also co-directors for the Texas Children's Hospital's Center for Vaccine Development -one of the most cutting-edge vaccine development centers in the world. For the past two decades it has acquired an international reputation as a non-profit Product Development Partnership (PDP), advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. One of their most notable achievements is the development of a vaccine technology leading to CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine.

"It's an honor to be recognized not only for our team's scientific efforts to develop and test low cost-effective vaccines for global health, but also for innovation in sustainable financing that goes beyond the traditional pharma business model," says Hotez in a statement.

The technology was created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability. Biological E Limited (BE) developed, produced and tested CORBEVAX in India where over 60 million children have been vaccinated so far.

Earlier this year, the doctors were nominated for the 2022 Nobel Peace Prize for their research and vaccine development of the vaccine. Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.

"We appreciate the recognition of our efforts to begin the long road to 'decolonize' the vaccine development ecosystem and make it more equitable. We hope that CORBEVAX becomes one of a pipeline of new vaccines developed against many neglected and emerging infections that adversely affect global public health," says Bottazzi in the news release from Texas Children's.

Fast Company editors and writers research candidates for the list throughout the year, scouting every business sector, including technology, medicine, engineering, marketing, entertainment, design, and social good. You can see the complete list here

.

Trending News